PPARD and atherosclerosis: Moreover, previous studies also have demonstrated that the activation of peroxisome proliferator-activated receptor δ (PPARδ) can not only inhibit the migration of VSMCs in plaques, but also inhibit apoptosis of VSMCs induced by ox-LDL, which indicate that PPARδ agonist may be a potential treatment for atherosclerosis [12,13].